Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
77 hedge funds and large institutions have $6.92M invested in Ampio Pharmaceuticals Inc. in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.
305% more call options, than puts
Call options by funds: $223K | Put options by funds: $55K
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
1% more funds holding
Funds holding: 76 → 77 (+1)
21% less capital invested
Capital invested by funds: $8.75M → $6.92M (-$1.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$1.07M |
| 2 |
WWM
Western Wealth Management
Golden,
Colorado
|
+$463K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$238K |
| 4 |
HC
HNP Capital
Rochester,
New York
|
+$229K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$85.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$606K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$324K |
| 3 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$318K |
| 4 |
Renaissance Technologies
New York
|
-$83K |
| 5 |
Millennium Management
New York
|
-$37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VFA
76
Valeo Financial Advisors
Carmel,
Indiana
| – | -$318K | -1,817 | Closed |
|
|
77
Renaissance Technologies
New York
| – | -$83K | -476 | Closed |
|
|
78
Millennium Management
New York
| – | -$37K | -213 | Closed |
|
|
SGCA
79
Steel Grove Capital Advisors
Memphis,
Tennessee
| – | -$32K | -185 | Closed |
|
80
UBS Group
Zurich,
Switzerland
| – | -$20.8K | -115 | -97% |
|
|
CCB
81
Cutter & Co Brokerage
Ballwin,
Missouri
| – | -$15K | -85 | Closed |
|
82
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$13K | -75 | Closed |
|
|
ACM
83
Anfield Capital Management
Irvine,
California
| – | -$2K | -12 | Closed |
|
|
CAGAS
84
Capital Advisory Group Advisory Services
Bloomington,
Minnesota
| – | +$543 | +3 | New |
|
AMPE Hedge Fund Activity: Q1 2020 in Review
77 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2020, worth a combined $6.92M — down 21% from $8.75M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new AMPE positions and 8 closed out — a net gain of 4 holders — while 17 added to existing stakes and 10 trimmed.
The largest buyer was Arax Advisory Partners, opening a new position worth an estimated $1.07M. The largest seller was Susquehanna International Group, cutting an estimated $606K.
- 77 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2020, up from 76 in Q4 2019.
- Funds reported $6.92M of Ampio Pharmaceuticals Inc. stock for Q1 2020, down 21% quarter-over-quarter.
- 12 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2020 and 8 closed out, a net change of +4 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2020 was Arax Advisory Partners, an estimated $1.07M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2020 was Susquehanna International Group, an estimated $606K sold.
Based on aggregated 13F filings for Q1 2020.